Brief: Herantis Pharma And Nanoform Sign A Letter Of Intent For Collaboration

Nanoform Finland Oyj

17/12/2020 17:20

Dec 17 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA AND NANOFORM SIGN A LETTER OF INTENT (LOI)
FOR
COLLABORATION
    * HERANTIS PHARMA - SIGNED A LOI FOR COLLABORATION TO SEEK
OPPORTUNITIES TO ENHANCE BLOOD BRAIN BARRIER PENETRATION OF CDNF
AND XCDNF MOLECULES
    * HERANTIS PHARMA - NANOFORM WILL SUBSCRIBE FOR SHARES IN
CO, FOR
AN AGGREGATE AMOUNT OF 1,600,000 EUROS, IN A PLANNED PRIVATE
PLACEMENT BY HERANTIS
    * PARTIES INTEND TO ENTER INTO A BINDING COLLABORATION
AGREEMENT
BASED ON LETTER OF INTENT

Source text for Eikon:  ID:nWkr6s64Ln 
Further company coverage:  HRTIS.HE 

 ((Reuters.Briefs@thomsonreuters.com;))